Tuesday, November 27, 2007

Evalve Pumps In $60M

Menlo Park-based medical device firm Evalve said Tuesday that it has raised $60M in a Series D financing. The firm said that the funding came from BBT Fund LP, which led the round, along with earlier investors Delphi Ventures, New Enterprise Associates, Split Rock Partners, and Abbott Laboratories. Evalve is developing medical devices for the percutaneous repair of cardiac valves. The firm said the funding would go towards commercialization of its devices in Europe, and toward U.S. approval of its product. More information »